Search all medical codes

Adverse effect of antineoplastic and immunosuppressive drugs

ICD10CM code

Similar Codes


ICD10CM codes

T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X5A - Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5S - Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X - Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
T45.1 - Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
T45.1X6 - Underdosing of antineoplastic and immunosuppressive drugs
T45.1X4 - Poisoning by antineoplastic and immunosuppressive drugs, undetermined
T45.1X6S - Underdosing of antineoplastic and immunosuppressive drugs, sequela
T45.1X1 - Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional)

HCPCS codes

J7599 - Immunosuppressive drug, not otherwise classified
J9999 - Not otherwise classified, antineoplastic drugs
S9359 - Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
J9055 - Injection, cetuximab, 10 mg
Q0510 - Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
D9610 - THERAPEUTIC PARENTERAL DRUG
J9227 - Injection, isatuximab-irfc, 10 mg
J9000 - Injection, doxorubicin hydrochloride, 10 mg
Q2050 - Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
G8927 - Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer

CPT4 codes

96402 - Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96401 - Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
80193 - Leflunomide
96549 - Unlisted chemotherapy procedure
96405 - Chemotherapy administration; intralesional, up to and including 7 lesions
96406 - Chemotherapy administration; intralesional, more than 7 lesions
80230 - Infliximab
4037F - Influenza immunization ordered or administered (COPD, PV, CKD, ESRD)(IBD)
80197 - Tacrolimus
80145 - Adalimumab